Real-World Utilization of Adalimumab Biosimilar (ABP 501) in Patients with Psoriasis in Europe

被引：0
|
作者：
Jin, Ran [1 ]
Wrest, Eleanor [2 ]
Haughton, James [2 ]
Piercy, James [2 ]
Meadows, Rachel [2 ]
Radziszewski, Waldemar [1 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA USA
[2] Adelphi Real World, Bollington, England
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB216 / AB216
页数：1
相关论文
共 50 条
  • [11] Use of adalimumab biosimilar ABP 501 in Crohn's disease: A real-life experience
    Ribaldone, D. G.
    Vernero, M.
    Pellicano, R.
    Morino, M.
    Saracco, G. M.
    Astegiano, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S510 - S511
  • [12] SPOSAB ABP 501-A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501
    Macaluso, Fabio Salvatore
    Cappello, Maria
    Busacca, Anita
    Fries, Walter
    Viola, Anna
    Costantino, Giuseppe
    Magnano, Antonio
    Vinci, Elisa
    Ferracane, Concetta
    Privitera, Antonino Carlo
    Piccillo, Giovita
    Belluardo, Nunzio
    Giangreco, Emiliano
    Romano, Claudio
    Citrano, Michele
    Graziano, Francesco
    Garufi, Serena
    Bertolami, Carmelo
    Ventimiglia, Marco
    Scrivo, Barbara
    Renna, Sara
    Giulia, Rizzuto
    Casa, Angelo
    Orlando, Ambrogio
    GASTROENTEROLOGY, 2021, 160 (03) : S80 - S80
  • [13] SPOSAB ABP 501-A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501
    Macaluso, Fabio Salvatore
    Cappello, Maria
    Busacca, Anita
    Fries, Walter
    Viola, Anna
    Costantino, Giuseppe
    Magnano, Antonio
    Vinci, Elisa
    Ferracane, Concetta
    Privitera, Antonino Carlo
    Piccillo, Giovita
    Belluardo, Nunzio
    Giangreco, Emiliano
    Romano, Claudio
    Citrano, Michele
    Graziano, Francesco
    Garufi, Serena
    Bertolami, Carmelo
    Ventimiglia, Marco
    Scrivo, Barbara
    Renna, Sara
    Giulia, Rizzuto
    Casa, Angelo
    Orlando, Ambrogio
    INFLAMMATORY BOWEL DISEASES, 2021, 27 : S59 - S59
  • [14] SPOSAB ABP 501-A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501
    Macaluso, F.
    Cappello, M.
    Busacca, A.
    Fries, W.
    Viola, A.
    Costantino, G.
    Magnano, A.
    Vinci, E.
    Ferracane, C.
    Privitera, A. C.
    Piccillo, G.
    Belluardo, N.
    Giangreco, E.
    Romano, C.
    Citrano, M.
    Graziano, F.
    Garufi, S.
    Bertolami, C.
    Scrivo, B.
    Renna, S.
    Casa, A.
    Rizzuto, G.
    Ventimiglia, M.
    Orlando, A.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S437 - S438
  • [15] Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab
    Liu, Jennifer
    Eris, Tamer
    Li, Cynthia
    Cao, Shawn
    Kuhns, Scott
    BIODRUGS, 2016, 30 (04) : 321 - 338
  • [16] Real-life data on efficacy and safety of original Adalimumab and biosimilar Adalimumab (ABP 501) in pediatric rheumatic diseases
    Ulu, Kadir
    Cakan, Mustafa
    Caglayan, Sengul
    Yigit, Ramazan Emre
    Demir, Ferhat
    Coskuner, Taner
    Kardes, Esra
    Sozeri, Betul
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (08) : 833 - 839
  • [17] Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab
    Jennifer Liu
    Tamer Eris
    Cynthia Li
    Shawn Cao
    Scott Kuhns
    BioDrugs, 2016, 30 : 321 - 338
  • [18] Immunogenicity after transition from adalimumab to ABP 501 in patients with plaque psoriasis
    Mytych, D.
    Miller, J.
    Manning, M. Starcevic
    Wala, I.
    Wang, H.
    Zhang, N.
    Krishnan, E.
    Kaliyaperumal, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S442 - S442
  • [19] Treatment Persistence and Switching Patterns of Adalimumab Biosimilar ABP 501 in European Patients with Rheumatologic Diseases
    Jin, Ran
    Kruppert, Silvia
    Scholz, Florian
    Bardoulat, Isabelle
    Karzazi, Khalil
    Morand, Francois
    Kricorian, Greg
    Collier, David
    Kay, Jonathan
    RHEUMATOLOGY AND THERAPY, 2024, 11 (03) : 523 - 537
  • [20] A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501
    Richard Markus
    Helen J. McBride
    Monica Ramchandani
    Vincent Chow
    Jennifer Liu
    Dan Mytych
    Gary Fanjiang
    Advances in Therapy, 2019, 36 : 1833 - 1850
12345